Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Cambridge-based biopharmaceutical company Sage Therapeutics filed a lawsuit against their partner, the biotechnology company ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in licensing deals, on average, than in 2023 with an eye toward enriching their ...

Needham & Company LLC reiterated their hold rating on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a research report report published on Wednesday,Benzinga reports. Other equities ...

Ventyx Biosciences Inc. (VTYX) stock has reached a 52-week low, trading at $1.57, marking a significant downturn for the biopharmaceutical company. With a market capitalization of $114.5 million, the ...

Needham & Company LLC restated their hold rating on shares of Gilead Sciences (NASDAQ:GILD – Free Report) in a research report sent to investors on Wednesday,Benzinga reports. Other analysts also ...

Sutro Biopharma Inc. (NASDAQ:STRO) shares have tumbled to a 52-week low, touching down at $1.67, as the biopharmaceutical company grapples with a challenging market environment. With a market ...

Quantum BioPharma Ltd (NASDAQ:QNTM) shares are rising Tuesday after the company announced positive clinical trial results for ...

MIRAMAR, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and ...

To manage these variations correctly, biopharmaceutical companies must obtain sufficient regulatory information. This entails the continuous tracking of regulatory changes, understanding of ...